LAURUSLABS acquisition, merger or stake sale
as of Wed 14 Oct 15:30
LAURUS LABS LIMITED filed acquisition, merger or stake sale of ₹108 crore, from KRKA Pharma Private Limited, its own share being 49% on Wed 14 Oct 2026.
Its size: <1% of the company's market value.
Where it came from
as of Wed 14 Oct 15:30
Sources
- Filed
- NSE · 2026-10-14 20:07 IST
- Document
raw/nse_announcement_docs/2026-10-14/d047519f1955_d047519f1955_LAURUSLABS_14102026200653_UpdateOnInvInKRKA14102026.pdf· SHA-256 d047519f1955- Read from
- “INR 1,078,000,000/- (Indian Rupees One Billion and Seventy -Eight Million only)” · page 1 · characters 981–1061
- Read by
- claude-haiku-4-5 · prompt 8c43350f344fef0c · 10 of 10 checks passed
- Measured against
- the company’s market value · as of 14 Oct 2026
- Kind
- acquisition, merger or stake sale
What such filings have been followed by
as of Wed 14 Oct 15:30
| Over | In | Beyond its normal day | Beyond what options priced |
|---|---|---|---|
| This stock | the next session | 1 of 10 | 7 of 10 |
| This stock | the next five sessions | 2 of 9 | 5 of 9 |
| Its industry (Healthcare) | the next session | 4 of 46 | 25 of 46 |
| Its industry (Healthcare) | the next five sessions | 6 of 45 | 19 of 45 |
| Every stock | the next session | 74 of 585 | 275 of 585 |
| Every stock | the next five sessions | 86 of 581 | 267 of 573 |
Counts of past filings of the same kind and size: of how many, how many were followed by a move bigger than the stock's own normal day, and bigger than what its options priced for the same span. A greyed row has fewer than 30 cases, too few to read as a tendency, and its counts are printed anyway. A filing whose sessions have not all arrived is not counted.